The Neuroprotective Shift

Eugene de Juan Jr. discusses his keynote on neuroprotection strategies at Glaucoma 360, emphasizing the necessity of addressing glaucoma beyond pressure control. Despite existing treatments, many patients progress due to compliance issues and limitations of current therapies. He highlights advancements in understanding neuroprotective pathways, particularly the DLK/LZK pathway, and the role of AI in trial designs. De Juan suggests neuroprotective therapies could reshape treatment, especially for patients with progressing or low-tension glaucoma, potentially integrating with improved diagnostic tools.